REFERENCES
- Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88–92
- Abdeel-Aleem H, Villar J, Glmezoglu AM, et al. The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration. Eur J Obstet Gynecol Reprod Biol 2003;108:25–8
- Tang OS, Schweer H, Seyberth HW, Lee SWH, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17:332–6
- Khan RE, El-Refaey H. Pharmacokinetics and adverse effect profile of rectally administered misoprostol in the third stage of labor. Obstet Gynecol 2003;101:968–74
- Meydanli MM, Caliskan E, Haberal A. Prediction of adverse outcome associated with vaginal misoprostol for labor induction. Eur J Obstet Gynecol Reprod Biol 2003;110:143–8
- Meydanli MM, Caliskan E, Burak F, Narin MA, Atmaca R. Labor induction post-term with 25 micrograms vs. 50 micrograms of intravaginal misoprostol. Int J Gynecol Obstet 2003;81:249–55
- Caliskan E, Dilbaz B, Meydanlı MM, øztrk N, Narin MA, Haberal A. Oral misoprostol for the third stage of labor: a randomized controlled trial. Obstet Gynecol 2003;101:921–8
- Kahn JG, Becker BJ, Maclsaa L, et al. The efficacy of medical abortion. Contraception 2000;61:29–40
- Mendilcioglu I, Simsek M, Seker PE, Erbay O, Zorlu CG, Trak B. Misoprostol in second and early third trimester for termination of pregnancies with fetal anomalies. Int J Gynecol Obstet 2002;79:131–5
- Ashok PW, Templeton A. Non-surgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynaecol 1999;106:706–10
- Sarkar NN. Mifepristone: bioavailability, pharmacoki- netics and use effectiveness. Eur J Obstet Gynecol 2002;101:113–20
- Danielsson KG, Marions L, Rodriguez A, Spur BW, Wong PY, Bygdeman M. Comparison between oral and vaginal administration of misoprostol on uterine con- tractility. Obstet Gynecol 1999;93:275–80
- Ho PC, Ngai SW, Liu KL, Wong GCY, Lee SWH. Vaginal misoprostol compared with oral misoprostol in termination of second trimester pregnancy. Obstet Gynecol 1997;90:735–8
- Ngai SW, Tang OS, Ho PC. Randomized comparison of vaginal (200 mg every 3 h) and oral (400 mg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy. Hum Reprod 2000;15:2205–8
- Bebbington MW, Kent N, Lim K, et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. Am J Obstet Gynecol 2002;187:853–7
- Chittacharoen A, Herabutya Y, Punyavachira P. A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstet Gynecol 2003;101:70–3
- Herabutya Y, O-Prasertsawat P. Second trimester abortion using intravaginal misoprostol. Int J Gynecol Obstet 1998;60:161–5
- Gonzalez JA, Carlan SJ, Alverson MW. Outpatient second trimester pregnancy termination. Contraception 2001;63:89–93
- Wong KS, Ngai CSW, Yeo ELK, Tang LCH, Ho PC. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Hum Reprod 2000;15:709–12
- Bartley J, Baird DT. A randomized study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy. Br J Obstet Gynaecol 2002;109:1290–4
- Dickinson JE, Evans SF. A comparison of oral mis- oprostol with vaginal misoprostol administration in second trimester termination for fetal abnormality. Obstet Gynecol 2003;101:1294–9
- Al-Hussaini TK. Uterine rupture in second trimester abortion in a grand multiparous woman: a complication of misoprostol and oxytocin. Eur J Obstet Gynecol Reprod Biol 2001;96:218–19
- Berghahn L, Christensen D, Droste S. Uterine rupture during second trimester abortion associated with mis- oprostol. Obstet Gynecol 2001;98:976–7